Mainit, Arnold L.
HRN: 25-16-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/02/2024
06/08/2024
TOPICAL
25g
BID
SEPSIS SEC. TO NIFU SEC. TO PAOD VS DM TYPE II
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes